PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies
RNA-seq data from HCC1569 cells treated with PRMT5 inhibitor C220 (PRT220)